{"id":47619,"date":"2022-08-24T16:02:20","date_gmt":"2022-08-24T14:02:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/"},"modified":"2022-08-24T16:02:20","modified_gmt":"2022-08-24T14:02:20","slug":"blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/","title":{"rendered":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer"},"content":{"rendered":"
\n

\nPOC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions<\/i>\n<\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE)–Each year in the United States, sepsis accounts for 270,000 deaths and costs nearly $27 billion \u2014 making it one of the largest cost drivers for U.S. hospitals.1<\/sup> <\/b>To quickly identify and best care for patients with sepsis or sepsis shock, Blessing Health System<\/a> (Blessing), an integrated health system in Quincy, Illinois, has selected POC Advisor<\/a> from Wolters Kluwer, Health<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nBy analyzing patient data in real-time and transforming it into actionable guidance, POC Advisor empowers clinicians to rapidly respond to sepsis symptoms and risk to make the most effective clinical decisions at the right time. The move expands Blessing’s adoption of Wolters Kluwer’s clinical surveillance suite by adding POC Advisor to its Sentri7 infection prevention and pharmacy surveillance solutions.\n<\/p>\n

\nPOC Advisor is in use at Blessing Hospital, the health system\u2019s acute care hospital in Quincy, IL, and at its critical-access hospital in Pittsfield, IL, Illini Community Hospital.\n<\/p>\n

\nThe first signs of sepsis: early and accurate detection<\/b>\n<\/p>\n

\nBlessing employs a collaborative approach to sepsis symptom detection and management with various care settings across the health system. Historically, this process was largely retrospective and relied on a multi-disciplinary group of clinicians to review cases, track data, and outcomes, and stay up to date on evolving guidelines and protocols for sepsis management. Now with a sepsis coordinator on board using POC Advisor’s centralized patient monitor and advanced analytics capabilities, Blessing can streamline manual, time-intensive processes. This sepsis surveillance solution monitors patients in real-time to better identify and alert on sepsis cases allowing clinicians to intervene earlier.\n<\/p>\n

\n“Early detection of sepsis is a challenge for many health systems, and we were determined to tackle this through more proactive monitoring,” said Mary Barthel, MD, Chief Quality and Safety Officer, Blessing Health System. “Using POC Advisor, we can now deliver real-time patient status updates to our clinicians so they can intervene immediately with an evidence-based approach to help save more lives and improve our sepsis bundle compliance. By combining advanced technology with our sepsis coordinator on the ground, we are better equipped to identify patients who develop sepsis earlier and optimize their care.”\n<\/p>\n

\nTracking sepsis amid changing patient conditions<\/b>\n<\/p>\n

\nEvery hour sepsis goes untreated mortality increases by about 8%.2<\/sup> Wolters Kluwer’s POC Advisor technology detects sepsis six hours earlier than common systemic inflammatory response syndrome (SIRS)-triggered electronic health record (EHR) alerts by analyzing a broad spectrum of real-time data, monitoring trends, and assessing all data in the context of the patient’s clinical status and co-morbid conditions. Alerts routed directly to a central monitor, into the EHR, or to point of care devices equip the bedside teams to act fast.\n<\/p>\n

\nAt Blessing, many providers rely on documenting patient conditions in text notes; POC Advisor’s natural language processing (NLP) scours clinical notes for critical information missing from standardized EHR data that might indicate sepsis. Coupled with evidence-based recommendations for the treatment of sepsis, POC Advisor helps improve patient outcomes by ensuring the delivery of bundle care components.\n<\/p>\n

\nWolters Kluwer’s team of clinical and informaticist experts supports the implementation. They optimize the use of POC Advisor by developing team workflows, building and maintaining the clinical rules that drive sepsis alerts, and providing detailed case reviews to clinical teams.\n<\/p>\n

\n“Clinicians are already overloaded with alerts. Our Wolters Kluwer team is helping healthcare providers like Blessing break through this noise so they have actionable, timely, and specific recommendations that allow them to deliver high-quality care that adheres to the most current evidence,” said Karen Kobelski<\/a>, Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions, Wolters Kluwer Health. “Blessing has made its sepsis program a priority, and we’re honored to work hand in hand with the Blessing team to seamlessly integrate sepsis alerts into provider workflows to achieve the hospital\u2019s goals.”\n<\/p>\n

\nLearn more about POC Advisor for sepsis identification and care management<\/a>.\n<\/p>\n

\nAbout Wolters Kluwer<\/b>\n<\/p>\n

\nWolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.\n<\/p>\n

\nWolters Kluwer reported 2021 annual revenues of \u20ac4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.\n<\/p>\n

\nWolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https:\/\/www.wolterskluwer.com\/en\/health<\/a> and follow us on LinkedIn<\/a> and Twitter @WKHealth<\/a>.\n<\/p>\n

\nFor more information, visit www.wolterskluwer.com<\/a>, follow us on Twitter<\/a>, Facebook<\/a>, LinkedIn<\/a>, and YouTube<\/a>.\n<\/p>\n

\n_______________________________\n<\/p>\n\n\n
\n

\n1<\/sup> Hatfield et al. (2018) Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries With Hospitalizations for Severe Sepsis and Septic Shock<\/a>. Critical Care Medicine.
\n
2<\/sup> Ferrer et al. (2014). Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour<\/a>. Critical Care Medicine.\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u00a0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Andr\u00e9 Rebelo
\n
Global Public Relations Associate Director
\n
Wolters Kluwer
\n
+1 (781) 392-2411
\n
andre.rebelo@wolterskluwer.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

POC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions WALTHAM, Mass.–(BUSINESS WIRE)–Each year in the United States, sepsis accounts for 270,000 deaths and costs nearly $27 billion \u2014 making it one of the largest cost drivers for U.S. hospitals.1 To quickly identify and best care for patients with sepsis … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47619","6":"format-standard","7":"category-industry"},"yoast_head":"\nBlessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"POC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions WALTHAM, Mass.–(BUSINESS WIRE)–Each year in the United States, sepsis accounts for 270,000 deaths and costs nearly $27 billion \u2014 making it one of the largest cost drivers for U.S. hospitals.1 To quickly identify and best care for patients with sepsis ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-24T14:02:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer\",\"datePublished\":\"2022-08-24T14:02:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/\"},\"wordCount\":896,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005429\\\/en\\\/1552379\\\/21\\\/WK_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/\",\"name\":\"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005429\\\/en\\\/1552379\\\/21\\\/WK_Logo.jpg\",\"datePublished\":\"2022-08-24T14:02:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005429\\\/en\\\/1552379\\\/21\\\/WK_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005429\\\/en\\\/1552379\\\/21\\\/WK_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/","og_locale":"en_US","og_type":"article","og_title":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend","og_description":"POC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions WALTHAM, Mass.–(BUSINESS WIRE)–Each year in the United States, sepsis accounts for 270,000 deaths and costs nearly $27 billion \u2014 making it one of the largest cost drivers for U.S. hospitals.1 To quickly identify and best care for patients with sepsis ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-24T14:02:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer","datePublished":"2022-08-24T14:02:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/"},"wordCount":896,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/","url":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/","name":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg","datePublished":"2022-08-24T14:02:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220824005429\/en\/1552379\/21\/WK_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/blessing-health-targets-smarter-sepsis-surveillance-with-wolters-kluwer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Blessing Health targets smarter sepsis surveillance with Wolters Kluwer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47619"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47619\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}